Kazia Therapeutics Ltd financial data

Symbol
KZIA on Nasdaq
Location
Three International Towers Level 24,, 300 Barangaroo Avenue, Sydney Nsw, Australia
State of incorporation
Australia
Fiscal year end
June 30
Former names
NOVOGEN LTD (to 11/17/2017)
Latest financial report
20-F - Q2 2024 - Nov 15, 2024

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 333M shares +46%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets 21.6M AUD -23.1%
Liabilities 31.6M AUD +97.1%